UCL awarded £6.5 million funding to translate research into global impact
21 June 2022
UCL has received the second highest amount of funding awarded by UK Research and Innovation (UKRI) as part of its Impact Acceleration Account (IAA) programme.
The university has secured £6.5 million of a total £118 million distributed by UKRI, second only to the University of Oxford.
IAA investment supports critical early-stage translation of UK research to real impacts. This funding goes towards projects that transform public services, create new jobs, attract private investment, and forge new partnerships with business and charities.
The IAA programme, now in its tenth year, has provided early-stage support to projects including:
- UCL spinout Bramble Energy, a hydrogen fuel cell technology company helping the world towards a Net Zero carbon future
- UCL spinout Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies
- A collaboration between Slade School of Fine Art and the Coal Authority to develop a range of paints from waste generated by de-commissioned coal mines
UCL Innovation & Enterprise manages and distributes the IAA programme funding through schemes available to all disciplines and departments. Regular funding calls are held throughout the year for projects that encourage connections beyond academia.
Dr Kathryn Walsh, Executive Director, UCL Innovation & Enterprise, said: "This funding is testament to the breadth of UCL research and innovation, which is enabling the brightest and most disruptive ideas to emerge in the UK and worldwide. It will mean UCL can continue to support academics to unlock the value of their work, whether it is early-stage commercialisation of new technologies or advancing changes to public policy.”
Find out more about:
- UCL Innovation & Enterprise funding opportunities
- UCL Translational Research Office
- Bramble Energy
- Orchard Therapeutics
- Turning Landscape
Photo © Tempest Photography